Percent of Long-Stay Residents Who Are Receiving Antianxiety Medications or Hypnotics

Identifying Attributes

Care Settings
Residential Aged Care
Country
United States of America
Publishing Organisation
Centers for Medicare & Medicaid Services (CMS): Minimum Data Set (MDS) 3.0 Resident Assessment Instrument Quality Measures
Type of Quality Indicator
Process
IOM Quality Dimension
Safety
Setting-Specific Domain
Medication-Related

Defining Attributes

Definition

Percent of long-stay residents who are receiving antianxiety medications or hypnotics

Numerator

Long-stay residents with a selected target assessment, where: Antianxiety medications or Hypnotic medications were received except those with exclusions.

Denominator

Long-stay residents with a selected target assessment, except those with exclusions.

Exclusions

Life expectancy <6 months, hospice care

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

None

Collection and Reporting Attributes

Type of Data Collection
Data Collection Methods
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Centers for Medicare and Medicaid Services (CMS) Minimum Data Set (MDS) 3.0 Resident Assessment Instrument Quality Measures

Link to Measurement Tools
Domain
Not Assigned
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
No
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Can the Quality Indicator be Readily Implemented at a Population Level in Australia Given its Current Data Landscape?
Implementation of this quality indicator was not assessed.
Identified by PHARMA-Care Project
Yes
Upload Date
23 July 2025